Collegium Pharmaceutical, Inc. - COLL

SEC FilingsOur COLL Tweets

About Gravity Analytica

Recent News

  • 02.12.2026 - Collegium to Report Fourth Quarter and Full-Year 2025 Financial Results on February 26, 2026
  • 01.15.2026 - Collegium to Present Four Real-World Data Posters at APSARD 2026 Annual Conference
  • 01.08.2026 - Collegium Provides 2026 Financial Guidance and Business Update
  • 12.30.2025 - Collegium Announces the Closing of $980 Million Syndicated Credit Facility

Recent Filings

  • 02.12.2026 - 4 Statement of changes in beneficial ownership of securities
  • 02.12.2026 - 4 Statement of changes in beneficial ownership of securities
  • 02.12.2026 - 4 Statement of changes in beneficial ownership of securities
  • 02.12.2026 - 4 Statement of changes in beneficial ownership of securities
  • 02.12.2026 - 4 Statement of changes in beneficial ownership of securities
  • 01.08.2026 - 8-K Current report
  • 01.08.2026 - EX-99.1 EX-99.1
  • 12.30.2025 - EX-99.1 EX-99.1
  • 12.30.2025 - 8-K Current report
  • 12.17.2025 - 144 Report of proposed sale of securities